US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATAI Life Sciences B.V.*

2.41

-0.0700-2.82%

Post-market: 2.430.0200+0.83%19:51 EDT

Volume:4.65M

Turnover:11.47M

Market Cap:483.81M

PE:-2.59

High:2.55

Open:2.55

Low:2.37

Close:2.48

Loading ...

Overview Company News Filings

ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings Summary

ATAI Life Sciences Reports Q1 2025 Net Loss of $26.4M, Down from $26.7M in Q1 2024, as G&A Expenses Decrease

Press Release: atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder

ATAI Life Sciences NV expected to post a loss of 18 cents a share - Earnings Preview

H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Atai Life Sciences initiated with a Positive at Berenberg

Calendar of U.S. Earnings Expected in the Week Ahead

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

ATAI Life Sciences Diversifies Treasury with Bitcoin Investment

ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Atai Life Sciences Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

TD Cowen Keeps Their Buy Rating on ATAI Life Sciences (ATAI)

ATAI Life Sciences Q4 EPS $(0.24) Misses $(0.15) Estimate

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

Atai Life Sciences completes enrollment of Phase 2b trial of BPL-003

atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ATAI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATAI\",,,,,undefined,":{"symbol":"ATAI","market":"US","secType":"STK","nameCN":"ATAI Life Sciences B.V.*","latestPrice":2.41,"timestamp":1749240000000,"preClose":2.48,"halted":0,"volume":4650851,"hourTrading":{"tag":"盘后","latestPrice":2.43,"preClose":2.41,"latestTime":"19:51 EDT","volume":5520,"amount":13310.5394,"timestamp":1749253901335},"delay":0,"floatShares":155000000,"shares":200752775,"eps":-0.931999,"marketStatus":"Market Closed","change":-0.07,"latestTime":"06-06 16:00:00 EDT","open":2.55,"high":2.55,"low":2.37,"amount":11466580.12348,"amplitude":0.072581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.931999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":2.48,"dividendRate":0.000415,"preHourTrading":{"tag":"盘前","latestPrice":2.53,"preClose":2.48,"latestTime":"09:29 EDT","volume":47784,"amount":120849.8263104,"timestamp":1749216542017},"postHourTrading":{"tag":"盘后","latestPrice":2.43,"preClose":2.41,"latestTime":"19:51 EDT","volume":5520,"amount":13310.5394,"timestamp":1749253901335},"volumeRatio":1.3917990269474791,"impliedVol":0.9166,"impliedVolPercentile":0.36},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATAI\",,,,,undefined,":{"symbol":"ATAI","floatShares":155000000,"roa":"-26.04%","roe":"-79.43%","lyrEps":-0.931999,"volumeRatio":1.3917990269474791,"shares":200752775,"dividePrice":0.001,"high":2.55,"amplitude":0.072581,"preClose":2.48,"low":2.37,"week52Low":1.03,"pbRate":"3.18","psRate":"259.70","week52High":2.64,"institutionHeld":0,"latestPrice":2.41,"eps":-0.931999,"divideRate":0.000415,"volume":4650851,"delay":0,"ttmEps":-0.931999,"open":2.55,"prevYearClose":1.33,"prevWeekClose":2.31,"prevMonthClose":2.31,"prevQuarterClose":1.36,"fiveDayClose":2.31,"twentyDayClose":1.4,"sixtyDayClose":1.45},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATAI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535025510","title":"ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025510","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025510?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:58","pubTimestamp":1747223938,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings SummaryATAI Life Sciences NV ATAI.OQ reported a quarterly adjusted loss of 15 cents per share for the quarter ended Marc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL8N3RM16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2535042989","title":"ATAI Life Sciences Reports Q1 2025 Net Loss of $26.4M, Down from $26.7M in Q1 2024, as G&A Expenses Decrease","url":"https://stock-news.laohu8.com/highlight/detail?id=2535042989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535042989?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220419,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATAI Life Sciences NV published the original content used to generate this news brief via GlobeNewswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL7h0V1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","LU2210150020.SGD","IE00B64PRP62.GBP","BK4112","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","BK4007","BK4539","LU2210149790.SGD","NDAQ","ATAI","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2535491042","title":"Press Release: atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535491042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535491042?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220400,"startTime":"0","endTime":"0","summary":"With clinical momentum across its pipeline, atai strengthens its position as a leader in potentially transformative psychedelic mental health treatments. -- Anticipate topline data midyear from the Phase 2b clinical trial of. BPL-003 in patients with treatment-resistant depression  - the. largest controlled trial of mebufotenin and the first and only such trial. -- Dosed the first patient in the exploratory Phase 2 study of EMP-01 (oral. R-MDMA) for the treatment of social anxiety; topline data anticipated in. -- Continued enrollment in Elumina, a Phase 2 study of VLS-01 (buccal film. DMT) in patients with TRD; topline data are anticipated in Q1'26. Cash, cash equivalents, short-term securities, and public equity holdings expected to fund operations into 2027. -- VLS-01 is an investigational proprietary oral transmucosal film. formulation of DMT applied to the buccal surface, design","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ATAI","CIAS","BK4007"],"gpt_icon":0},{"id":"2535722493","title":"Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722493","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535722493?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:54","pubTimestamp":1747137259,"startTime":"0","endTime":"0","summary":"May 13 (Reuters) - :*ATAI LIFE SCIENCES ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 STUDY OF EMP-01 FOR THE TREATMENT OF SOCIAL ANXIETY DISORDER*ATAI LIFE SCIENCES NV - TOPLINE DATA EXPECTED IN Q1 2026  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nRSD9sfpkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0},{"id":"2534488370","title":"ATAI Life Sciences NV  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534488370","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534488370?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:29","pubTimestamp":1746790146,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV  expected to post a loss of18cents a share - Earnings Preview ATAI Life Sciences NV ATAI.OQ, ATAI.O is expected to show no change in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH1BZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2532184007","title":"H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532184007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532184007?lang=en_us&edition=fundamental","pubTime":"2025-05-01 23:56","pubTimestamp":1746114997,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences (ATAI – Research Report), with a pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATAI","BK4007","BK4539"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IXHL","MIRA","DRUG","BK4202","MYCOF","ENVB","BK4539","PBM","SPRC","CYBN","GHRS","MNMD","NUMIF","BK4547","ALID","OPTHF","SILO","CMPS","RLMD","BETRF","MDXXF","ENTBF","FLHLF","NRXP","AGNPF","BK4168","BK4007","SEEL","ATAI","SNPX","BK4139","PHRRF","RVVTF","PSYGF","QNTM","KTTA","CMND"],"gpt_icon":0},{"id":"2524327966","title":"Atai Life Sciences initiated with a Positive at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2524327966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524327966?lang=en_us&edition=fundamental","pubTime":"2025-04-04 16:31","pubTimestamp":1743755491,"startTime":"0","endTime":"0","summary":"Berenberg initiated coverage of Atai Life Sciences (ATAI) with a Positive rating. Atai has an “exciting” portfolio of psychedelic drug candidates t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-initiated-with-a-positive-at-berenberg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-initiated-with-a-positive-at-berenberg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ATAI","BK4539"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDL","DARE","LULU","FC","TSAT","ATAI","TLSI","PVLA","PRGS","CELC","REKR","SGML","BCAB","AFMD","GWH","GOVX","EDAP","SLRN","SPWH","SKYH","BW","FTCI","PENG","WGO","BLRX","BRZE","NCNO","UNCY","RANI","WKSP","CALC","INR","CLSD","SDST","FEMY","NUTX","PVH","MDAI","GEVO","RLMD","KYTX","WBA","LNZA","NNOX","ANGO","ADCT","IKT","INMB","BHST","FBIO"],"gpt_icon":0},{"id":"2521172612","title":"Psychedelic: Exclusive talk with biotech company Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172612","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 22:30","pubTimestamp":1742653811,"startTime":"0","endTime":"0","summary":"In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind Medicine , a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems. Here are some highlights:. Discover stocks' market position with detailed  competitor analyses.“Think of this space as being two overlapping circles, a Venn diagram,” Haden said. “There are addiction treatments, like counseling, Alcoholics Anonymous and some pharmaceutical interventions like Antabuse, naltrexone and acamprosate. I ran an addictions treatment program for 28 years and I can assure you that there is relatively low efficacy, the dropout rate is high, and the treatments tend to be very long-term. That’s the first circle.”“You can take MEAI if you are addicted to alcohol and you don’t want to stop,” Haden said. “You can add MEAI to your alcohol and we believe it will result in people drinking less. It c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","MYCOF","PBM","ENTBF","AGNPF","CYBN","BETRF","DRUG","RVVTF","BK4539","NUMIF","SPRC","BK4007","SEEL","RLMD","CMPS","PHRRF","CMND","SNPX","BK4547","MIRA","ALID","GHRS","PSYGF","MNMD","QNTM","ATAI","SILO","MDXXF","IXHL","BK4139","NRXP","OPTHF","KTTA","BK4168","FLHLF"],"gpt_icon":0},{"id":"2520945548","title":"ATAI Life Sciences Diversifies Treasury with Bitcoin Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520945548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520945548?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:18","pubTimestamp":1742473122,"startTime":"0","endTime":"0","summary":"An announcement from ATAI Life Sciences ( ($ATAI) ) is now available. On March 20, 2025, ATAI Life Sciences announced its decision to diversify its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atai-life-sciences-diversifies-treasury-with-bitcoin-investment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atai-life-sciences-diversifies-treasury-with-bitcoin-investment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","US10Y.BOND","US5Y.BOND","BK4601","BK4007","BK4594","ATAI","BK4539","US30Y.BOND","US7Y.BOND","US3Y.BOND","US2Y.BOND","US12M.BOND","US6M.BOND","BK4585"],"gpt_icon":0},{"id":"2520152002","title":"ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520152002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520152002?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:41","pubTimestamp":1742402460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2025 12:41 ET (16:41 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2520882411","title":"Atai Life Sciences Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2520882411","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520882411?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:42","pubTimestamp":1742380922,"startTime":"0","endTime":"0","summary":"NasdaqGM:ATAI Earnings and Revenue History March 19th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 44%. Earnings per share  also missed analyst estimates by 18%.Looking ahead, revenue is forecast to grow 67% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 4.9% from a week ago.Be aware that  Atai Life Sciences is showing  3 warning signs in our investment analysis and 1 of those can't be ignored...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atai-life-sciences-full-2024-104202350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATAI"],"gpt_icon":0},{"id":"2520350029","title":"TD Cowen Keeps Their Buy Rating on ATAI Life Sciences (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520350029","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520350029?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:55","pubTimestamp":1742241311,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on ATAI Life Sciences (ATAI – Research Report) today. The company’s shares opened today at $1.4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","COWN","ATAI"],"gpt_icon":0},{"id":"2520854091","title":"ATAI Life Sciences Q4 EPS $(0.24) Misses $(0.15) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520854091","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520854091?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:07","pubTimestamp":1742213233,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.15) by 60 percent. This is a 100 percent decrease over losses of $(0.12) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44354325/atai-life-sciences-q4-eps-0-24-misses-0-15-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ATAI Life Sciences Q4 EPS $(0.24) Misses $(0.15) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2520409455","title":"atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2520409455","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520409455?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:00","pubTimestamp":1742212800,"startTime":"0","endTime":"0","summary":"- Dosed the first patient in the Phase 2 Elumina trial of VLS-01 (buccal film DMT) for patients with treatment-resistant depression; topline data anticipated in Q1’26 - Initiated a Phase 2 clinical tr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/17/3043651/0/en/atai-Life-Sciences-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Corporate-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI","BK4539","CIAS","BK4007"],"gpt_icon":0},{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IXHL","MNMD","PSYGF","DRUG","SPRC","MDXXF","RVVTF","BK4202","BK4547","FLHLF","BK4139","AGNPF","SEEL","GHRS","OPTHF","ATAI","ENVB","NUMIF","BK4539","RLMD","QNTM","BK4168","ALID","BETRF","CMND","PBM","CMPS","NRXP","BK4007","SNPX","SILO","MIRA","ENTBF","KTTA","MYCOF","CYBN","PHRRF"],"gpt_icon":0},{"id":"2518712898","title":"atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2518712898","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518712898?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:00","pubTimestamp":1741690800,"startTime":"0","endTime":"0","summary":"- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering from t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040405/0/en/atai-Life-Sciences-Announces-First-Patient-Dosed-in-Elumina-the-Phase-2-Clinical-Trial-of-VLS-01-for-Treatment-Resistant-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2517915415","title":"Atai Life Sciences completes enrollment of Phase 2b trial of BPL-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2517915415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517915415?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:16","pubTimestamp":1741176962,"startTime":"0","endTime":"0","summary":"atai Life Sciences (ATAI) announced the completion of patient enrollment in the eight-week, double-blind, core stage of the global Phase 2b clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-completes-enrollment-of-phase-2b-trial-of-bpl-003?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-completes-enrollment-of-phase-2b-trial-of-bpl-003?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2517435913","title":"atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2517435913","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517435913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"- The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and safety of a single dose of BPL-003  in patients with treatment-resistant depression. - The open-label extension stage of the Phase 2b clinical trial continues to enroll patients to evaluate the safety and efficacy of a second dose of BPL-003. - As previously reported, the Phase 2a study of BPL-003 in patients with treatment-resistant depression showed rapid and lasting antidepressant effects from a single dose, and patients were deemed ready for discharge within an average time of less than two hours after dosing. The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial  is evaluating the efficacy and safety of a single medium  or high  dose of BPL-003 against a sub-perceptual dose. The trial enrolled 196 patients with moderate-to-severe depression that had failed to respond to at least two or more prior treatments in the current ep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atai-life-sciences-announces-completion-120000311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ATAI","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-03-17","symbol":"ATAI","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-11-13","symbol":"ATAI","fiscalQuarterEnding":"2024/09","expectedEps":-0.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2024-08-13","symbol":"ATAI","fiscalQuarterEnding":"2024/06","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-05-15","symbol":"ATAI","fiscalQuarterEnding":"2024/03","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1712203200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATAI","date":"2025-06-06","current":-3.34168,"percent":0.461459,"low":-16.362892,"twenty":-6.824612,"median":-3.130675,"eighty":-1.953787,"high":-0.988908,"avg":-4.510588,"sd":3.423242,"marketCap":497866882},"quantilePoints":[{"date":"2021-06-18","current":-16.000917,"twenty":-14.513466,"median":-12.28229,"eighty":-12.28229,"marketCap":2967482143},{"date":"2021-06-25","current":-13.936018,"twenty":-15.793605,"median":-14.964354,"eighty":-12.943781,"marketCap":2584532005},{"date":"2021-07-02","current":-14.832727,"twenty":-15.377334,"median":-14.832727,"eighty":-14.222307,"marketCap":2750833061},{"date":"2021-07-09","current":-15.285195,"twenty":-15.443148,"median":-14.832727,"eighty":-14.447718,"marketCap":2834746438},{"date":"2021-07-16","current":-14.297992,"twenty":-15.474409,"median":-14.857407,"eighty":-14.447718,"marketCap":2651662706},{"date":"2021-07-23","current":-14.297992,"twenty":-15.410241,"median":-14.758687,"eighty":-14.219016,"marketCap":2651662706},{"date":"2021-07-30","current":-12.751374,"twenty":-15.272032,"median":-14.65174,"eighty":-13.50823,"marketCap":2364831528},{"date":"2021-08-06","current":-11.829984,"twenty":-15.199638,"median":-14.396712,"eighty":-12.935651,"marketCap":2193953378},{"date":"2021-08-13","current":-11.204756,"twenty":-15.112434,"median":-14.248632,"eighty":-12.28229,"marketCap":2078000349},{"date":"2021-08-20","current":-10.560325,"twenty":-15.04004,"median":-13.977151,"eighty":-11.857955,"marketCap":2297525475},{"date":"2021-08-27","current":-11.812763,"twenty":-14.872215,"median":-13.384829,"eighty":-11.681826,"marketCap":2570008281},{"date":"2021-09-03","current":-12.211266,"twenty":-14.827791,"median":-13.212069,"eighty":-11.659054,"marketCap":2656707356},{"date":"2021-09-10","current":-11.713137,"twenty":-14.808047,"median":-12.751374,"eighty":-11.67044,"marketCap":2548333512},{"date":"2021-09-17","current":-11.684673,"twenty":-14.758687,"median":-12.498145,"eighty":-11.521002,"marketCap":2542140721},{"date":"2021-09-24","current":-11.385795,"twenty":-14.692873,"median":-12.28229,"eighty":-11.428492,"marketCap":2477116416},{"date":"2021-10-01","current":-9.862945,"twenty":-14.65174,"median":-12.152252,"eighty":-11.204756,"marketCap":2145802095},{"date":"2021-10-08","current":-8.930733,"twenty":-14.65174,"median":-12.027425,"eighty":-11.122499,"marketCap":1942988188},{"date":"2021-10-15","current":-9.606765,"twenty":-14.470753,"median":-11.899911,"eighty":-10.837854,"marketCap":2090066976},{"date":"2021-10-22","current":-10.852086,"twenty":-14.396712,"median":-11.764171,"eighty":-10.560325,"marketCap":2361001584},{"date":"2021-10-29","current":-10.382422,"twenty":-14.297992,"median":-11.698905,"eighty":-10.432235,"marketCap":2258820531},{"date":"2021-11-05","current":-12.225498,"twenty":-14.297992,"median":-11.727369,"eighty":-10.49628,"marketCap":2659803751},{"date":"2021-11-12","current":-10.617254,"twenty":-14.199272,"median":-11.698905,"eighty":-10.49628,"marketCap":2309911057},{"date":"2021-11-19","current":-11.282109,"twenty":-13.993604,"median":-11.713137,"eighty":-10.524745,"marketCap":1867471140},{"date":"2021-11-26","current":-10.836635,"twenty":-13.980442,"median":-11.67044,"eighty":-10.52127,"marketCap":1793734082},{"date":"2021-12-03","current":-10.245898,"twenty":-13.944245,"median":-11.617248,"eighty":-10.52127,"marketCap":1695952332},{"date":"2021-12-10","current":-10.488004,"twenty":-13.50823,"median":-11.521002,"eighty":-10.494625,"marketCap":1736026820},{"date":"2021-12-17","current":-7.737687,"twenty":-13.374957,"median":-11.424934,"eighty":-10.429389,"marketCap":1280780636},{"date":"2021-12-23","current":-7.476213,"twenty":-13.358504,"median":-11.360889,"eighty":-10.36819,"marketCap":1237500189},{"date":"2021-12-31","current":-7.389055,"twenty":-13.26801,"median":-11.204756,"eighty":-10.150437,"marketCap":1223073373},{"date":"2022-01-07","current":-6.217265,"twenty":-13.004756,"median":-11.147405,"eighty":-9.828788,"marketCap":1029112851},{"date":"2022-01-14","current":-5.771792,"twenty":-12.797443,"median":-11.108267,"eighty":-9.539873,"marketCap":955375793},{"date":"2022-01-21","current":-5.093897,"twenty":-12.728889,"median":-11.044222,"eighty":-9.23815,"marketCap":843167227},{"date":"2022-01-28","current":-4.784002,"twenty":-12.689469,"median":-10.952279,"eighty":-8.879497,"marketCap":791871882},{"date":"2022-02-04","current":-4.968002,"twenty":-12.675237,"median":-10.904425,"eighty":-7.737687,"marketCap":822328493},{"date":"2022-02-11","current":-5.365055,"twenty":-12.577704,"median":-10.837245,"eighty":-7.400676,"marketCap":888050654},{"date":"2022-02-18","current":-5.60716,"twenty":-12.392673,"median":-10.817267,"eighty":-7.106276,"marketCap":928125142},{"date":"2022-02-25","current":-5.35537,"twenty":-12.308745,"median":-10.795157,"eighty":-6.542655,"marketCap":886447674},{"date":"2022-03-04","current":-4.958318,"twenty":-12.28229,"median":-10.657477,"eighty":-6.221139,"marketCap":820725514},{"date":"2022-03-11","current":-5.05516,"twenty":-12.280894,"median":-10.617254,"eighty":-5.82215,"marketCap":836755309},{"date":"2022-03-18","current":-5.471581,"twenty":-12.275311,"median":-10.563883,"eighty":-5.583918,"marketCap":905683428},{"date":"2022-03-25","current":-4.909896,"twenty":-12.265348,"median":-10.524745,"eighty":-5.483202,"marketCap":812710616},{"date":"2022-04-01","current":-5.094954,"twenty":-12.222652,"median":-10.492142,"eighty":-5.388297,"marketCap":854973992},{"date":"2022-04-08","current":-4.740605,"twenty":-12.188494,"median":-10.432235,"eighty":-5.366992,"marketCap":795511515},{"date":"2022-04-14","current":-5.094954,"twenty":-12.097408,"median":-10.382422,"eighty":-5.306949,"marketCap":854973992},{"date":"2022-04-22","current":-4.577797,"twenty":-12.093238,"median":-10.307044,"eighty":-5.219791,"marketCap":768190917},{"date":"2022-04-29","current":-4.109123,"twenty":-12.076059,"median":-10.190287,"eighty":-5.114108,"marketCap":689543647},{"date":"2022-05-06","current":-3.697253,"twenty":-12.027425,"median":-10.00171,"eighty":-5.093897,"marketCap":620428550},{"date":"2022-05-13","current":-3.486528,"twenty":-11.976434,"median":-9.777552,"eighty":-5.05516,"marketCap":585067337},{"date":"2022-05-20","current":-3.130675,"twenty":-11.969838,"median":-9.603207,"eighty":-4.977686,"marketCap":642931140},{"date":"2022-05-27","current":-3.185462,"twenty":-11.892215,"median":-9.371933,"eighty":-4.958318,"marketCap":654182434},{"date":"2022-06-03","current":-2.888048,"twenty":-11.885582,"median":-9.22961,"eighty":-4.898937,"marketCap":593103976},{"date":"2022-06-10","current":-2.57498,"twenty":-11.840772,"median":-8.941408,"eighty":-4.879612,"marketCap":528810862},{"date":"2022-06-17","current":-2.543674,"twenty":-11.81779,"median":-8.076634,"eighty":-4.813054,"marketCap":522381551},{"date":"2022-06-24","current":-2.966315,"twenty":-11.813554,"median":-7.737687,"eighty":-4.774305,"marketCap":609177255},{"date":"2022-07-01","current":-2.856741,"twenty":-11.783608,"median":-7.529477,"eighty":-4.711874,"marketCap":586674665},{"date":"2022-07-08","current":-3.373303,"twenty":-11.74945,"median":-7.403581,"eighty":-4.629513,"marketCap":692758303},{"date":"2022-07-15","current":-3.326343,"twenty":-11.721676,"median":-7.253476,"eighty":-4.405411,"marketCap":683114336},{"date":"2022-07-22","current":-3.044582,"twenty":-11.701751,"median":-7.050108,"eighty":-4.202991,"marketCap":625250533},{"date":"2022-07-29","current":-3.021102,"twenty":-11.67898,"median":-6.52716,"eighty":-3.570818,"marketCap":620428550},{"date":"2022-08-05","current":-3.428089,"twenty":-11.664747,"median":-6.314108,"eighty":-3.385825,"marketCap":704009598},{"date":"2022-08-12","current":-3.584623,"twenty":-11.647669,"median":-6.178529,"eighty":-3.414001,"marketCap":736156155},{"date":"2022-08-19","current":-3.779551,"twenty":-11.620771,"median":-5.897686,"eighty":-3.437481,"marketCap":731426327},{"date":"2022-08-26","current":-3.913341,"twenty":-11.593801,"median":-5.616844,"eighty":-3.45157,"marketCap":757317525},{"date":"2022-09-02","current":-3.645762,"twenty":-11.559429,"median":-5.573265,"eighty":-3.457831,"marketCap":705535130},{"date":"2022-09-09","current":-3.6374,"twenty":-11.512049,"median":-5.544213,"eighty":-3.467223,"marketCap":703916930},{"date":"2022-09-16","current":-3.22767,"twenty":-11.466687,"median":-5.471581,"eighty":-3.45157,"marketCap":624625138},{"date":"2022-09-23","current":-2.759988,"twenty":-11.427069,"median":-5.394107,"eighty":-3.350449,"marketCap":534118488},{"date":"2022-09-30","current":-2.837131,"twenty":-11.41426,"median":-5.374739,"eighty":-3.307558,"marketCap":549047266},{"date":"2022-10-07","current":-2.888559,"twenty":-11.375833,"median":-5.360212,"eighty":-3.252772,"marketCap":558999784},{"date":"2022-10-14","current":-2.579989,"twenty":-11.325208,"median":-5.306949,"eighty":-3.218334,"marketCap":499284674},{"date":"2022-10-21","current":-2.451418,"twenty":-11.266638,"median":-5.248844,"eighty":-3.163869,"marketCap":474403378},{"date":"2022-10-28","current":-2.571418,"twenty":-11.198267,"median":-5.190739,"eighty":-3.130675,"marketCap":497625921},{"date":"2022-11-04","current":-2.579989,"twenty":-11.169465,"median":-5.133055,"eighty":-3.10835,"marketCap":499284674},{"date":"2022-11-11","current":-2.324356,"twenty":-11.153809,"median":-5.094954,"eighty":-3.046147,"marketCap":456157094},{"date":"2022-11-18","current":-2.594826,"twenty":-11.133885,"median":-5.089637,"eighty":-3.008579,"marketCap":509237192},{"date":"2022-11-25","current":-2.61173,"twenty":-11.122499,"median":-5.05516,"eighty":-2.966315,"marketCap":512554698},{"date":"2022-12-02","current":-3.000532,"twenty":-11.108267,"median":-5.035791,"eighty":-2.958488,"marketCap":588857339},{"date":"2022-12-09","current":-2.704705,"twenty":-11.051338,"median":-4.977686,"eighty":-2.927181,"marketCap":530800982},{"date":"2022-12-16","current":-2.61173,"twenty":-11.044222,"median":-4.970453,"eighty":-2.897131,"marketCap":512554698},{"date":"2022-12-23","current":-2.256738,"twenty":-11.020636,"median":-4.934107,"eighty":-2.888559,"marketCap":442887069},{"date":"2022-12-30","current":-2.248286,"twenty":-10.966404,"median":-4.905054,"eighty":-2.87709,"marketCap":441228316},{"date":"2023-01-06","current":-1.538301,"twenty":-10.952166,"median":-4.892183,"eighty":-2.856741,"marketCap":301893058},{"date":"2023-01-13","current":-1.521396,"twenty":-10.943173,"median":-4.880844,"eighty":-2.85213,"marketCap":298575552},{"date":"2023-01-20","current":-1.605918,"twenty":-10.924258,"median":-4.874683,"eighty":-2.840559,"marketCap":315163083},{"date":"2023-01-27","current":-1.512944,"twenty":-10.883489,"median":-4.813054,"eighty":-2.800636,"marketCap":296916799},{"date":"2023-02-03","current":-1.580562,"twenty":-10.846393,"median":-4.784002,"eighty":-2.749703,"marketCap":310186824},{"date":"2023-02-10","current":-1.479135,"twenty":-10.837366,"median":-4.733251,"eighty":-2.691417,"marketCap":290281787},{"date":"2023-02-17","current":-1.597466,"twenty":-10.832761,"median":-4.711874,"eighty":-2.670896,"marketCap":313504330},{"date":"2023-02-24","current":-1.369257,"twenty":-10.825014,"median":-4.66399,"eighty":-2.64229,"marketCap":268717997},{"date":"2023-03-03","current":-1.318543,"twenty":-10.815691,"median":-4.545321,"eighty":-2.613421,"marketCap":258765478},{"date":"2023-03-10","current":-1.124143,"twenty":-10.806543,"median":-4.405411,"eighty":-2.591472,"marketCap":220614158},{"date":"2023-03-17","current":-1.031169,"twenty":-10.793768,"median":-4.223755,"eighty":-2.579989,"marketCap":202367874},{"date":"2023-03-24","current":-1.361769,"twenty":-10.764972,"median":-4.109123,"eighty":-2.564171,"marketCap":207513095},{"date":"2023-03-31","current":-1.971841,"twenty":-10.666193,"median":-3.984416,"eighty":-2.543762,"marketCap":300478961},{"date":"2023-04-06","current":-1.830217,"twenty":-10.642951,"median":-3.913341,"eighty":-2.519989,"marketCap":278897599},{"date":"2023-04-14","current":-2.17883,"twenty":-10.633267,"median":-3.86317,"eighty":-2.477133,"marketCap":332020952},{"date":"2023-04-21","current":-2.385818,"twenty":-10.617254,"median":-3.783732,"eighty":-2.434234,"marketCap":363562942},{"date":"2023-04-28","current":-2.037206,"twenty":-10.575162,"median":-3.697253,"eighty":-2.425704,"marketCap":310439590},{"date":"2023-05-05","current":-2.124359,"twenty":-10.567441,"median":-3.666869,"eighty":-2.385818,"marketCap":323720428},{"date":"2023-05-12","current":-2.135253,"twenty":-10.560325,"median":-3.6374,"eighty":-2.331419,"marketCap":325380532},{"date":"2023-05-19","current":-2.077211,"twenty":-10.524745,"median":-3.587229,"eighty":-2.254276,"marketCap":308779485},{"date":"2023-05-26","current":-1.976701,"twenty":-10.524745,"median":-3.584623,"eighty":-2.2333,"marketCap":293838542},{"date":"2023-06-02","current":-1.920862,"twenty":-10.510847,"median":-3.520334,"eighty":-2.189724,"marketCap":285538018},{"date":"2023-06-09","current":-1.999036,"twenty":-10.498498,"median":-3.467223,"eighty":-2.177507,"marketCap":297158752},{"date":"2023-06-16","current":-1.999036,"twenty":-10.491314,"median":-3.456685,"eighty":-2.152683,"marketCap":297158752},{"date":"2023-06-23","current":-1.731009,"twenty":-10.476383,"median":-3.43983,"eighty":-2.128717,"marketCap":257316237},{"date":"2023-06-30","current":-1.820352,"twenty":-10.453608,"median":-3.388956,"eighty":-2.121882,"marketCap":270597075},{"date":"2023-07-07","current":-2.121882,"twenty":-10.432235,"median":-3.343366,"eighty":-2.121882,"marketCap":315419904},{"date":"2023-07-14","current":-2.278231,"twenty":-10.418003,"median":-3.326343,"eighty":-2.121882,"marketCap":338661371},{"date":"2023-07-21","current":-2.311735,"twenty":-10.382422,"median":-3.283295,"eighty":-2.121882,"marketCap":343641685},{"date":"2023-07-28","current":-2.278231,"twenty":-10.36819,"median":-3.248076,"eighty":-2.121882,"marketCap":338661371},{"date":"2023-08-04","current":-2.155386,"twenty":-10.36819,"median":-3.226133,"eighty":-2.124359,"marketCap":320400218},{"date":"2023-08-11","current":-1.909694,"twenty":-10.245898,"median":-3.199177,"eighty":-2.121882,"marketCap":283877913},{"date":"2023-08-18","current":-1.819437,"twenty":-10.245898,"median":-3.166698,"eighty":-2.099547,"marketCap":263956656},{"date":"2023-08-25","current":-1.785108,"twenty":-10.190287,"median":-3.145701,"eighty":-2.077211,"marketCap":258976342},{"date":"2023-09-01","current":-1.750779,"twenty":-10.090661,"median":-3.122848,"eighty":-2.0481,"marketCap":253996028},{"date":"2023-09-08","current":-1.659235,"twenty":-10.056503,"median":-3.113997,"eighty":-2.036273,"marketCap":240715190},{"date":"2023-09-15","current":-1.659235,"twenty":-9.973957,"median":-3.068062,"eighty":-2.021372,"marketCap":240715190},{"date":"2023-09-22","current":-1.499033,"twenty":-9.881447,"median":-3.048495,"eighty":-1.999036,"marketCap":217473723},{"date":"2023-09-29","current":-1.48759,"twenty":-9.794631,"median":-3.028928,"eighty":-1.986842,"marketCap":215813618},{"date":"2023-10-06","current":-1.739336,"twenty":-9.718376,"median":-3.00299,"eighty":-1.975729,"marketCap":252335923},{"date":"2023-10-13","current":-1.430375,"twenty":-9.626128,"median":-2.989795,"eighty":-1.963299,"marketCap":207513095},{"date":"2023-10-20","current":-1.476147,"twenty":-9.601072,"median":-2.966009,"eighty":-1.935811,"marketCap":214153514},{"date":"2023-10-27","current":-1.304502,"twenty":-9.569761,"median":-2.962095,"eighty":-1.921174,"marketCap":189251942},{"date":"2023-11-03","current":-1.418932,"twenty":-9.434555,"median":-2.948559,"eighty":-1.901569,"marketCap":205852990},{"date":"2023-11-10","current":-1.350274,"twenty":-9.347738,"median":-2.925013,"eighty":-1.841353,"marketCap":195892361},{"date":"2023-11-17","current":-2.752665,"twenty":-9.246689,"median":-2.922845,"eighty":-1.841353,"marketCap":184271628},{"date":"2023-11-24","current":-2.727866,"twenty":-9.22961,"median":-2.905702,"eighty":-1.842323,"marketCap":182611523},{"date":"2023-12-01","current":-2.579073,"twenty":-9.080172,"median":-2.896503,"eighty":-1.865209,"marketCap":172650895},{"date":"2023-12-08","current":-2.901457,"twenty":-8.952082,"median":-2.895875,"eighty":-1.865209,"marketCap":194232256},{"date":"2023-12-15","current":-3.174244,"twenty":-8.930733,"median":-2.895875,"eighty":-1.899538,"marketCap":212493409},{"date":"2023-12-22","current":-3.223841,"twenty":-8.84534,"median":-2.897131,"eighty":-1.909694,"marketCap":215813618},{"date":"2023-12-29","current":-3.695018,"twenty":-8.384116,"median":-2.90358,"eighty":-1.910466,"marketCap":247355609},{"date":"2024-01-05","current":-4.26539,"twenty":-8.016592,"median":-2.914274,"eighty":-1.912259,"marketCap":285538018},{"date":"2024-01-12","current":-4.959756,"twenty":-7.768677,"median":-2.934273,"eighty":-1.918068,"marketCap":332020952},{"date":"2024-01-19","current":-4.389384,"twenty":-7.737687,"median":-2.94961,"eighty":-1.920862,"marketCap":293838542},{"date":"2024-01-26","current":-4.314988,"twenty":-7.737687,"median":-2.965702,"eighty":-1.922424,"marketCap":288858228},{"date":"2024-02-02","current":-4.488579,"twenty":-7.58274,"median":-2.979741,"eighty":-1.939158,"marketCap":300478961},{"date":"2024-02-09","current":-4.339787,"twenty":-7.476213,"median":-2.998031,"eighty":-1.939158,"marketCap":290518333},{"date":"2024-02-16","current":-4.46378,"twenty":-7.418108,"median":-3.000652,"eighty":-1.954365,"marketCap":298818856},{"date":"2024-02-23","current":-4.538177,"twenty":-7.394866,"median":-3.013275,"eighty":-1.954365,"marketCap":303799171},{"date":"2024-03-01","current":-4.810963,"twenty":-7.350318,"median":-3.044582,"eighty":-1.963299,"marketCap":322060323},{"date":"2024-03-08","current":-5.430933,"twenty":-7.270908,"median":-3.060235,"eighty":-1.965533,"marketCap":363562942},{"date":"2024-03-15","current":-4.166195,"twenty":-7.145013,"median":-3.107195,"eighty":-1.970579,"marketCap":278897599},{"date":"2024-03-22","current":-4.141396,"twenty":-7.102403,"median":-3.113997,"eighty":-1.971841,"marketCap":277237494},{"date":"2024-03-28","current":-4.438982,"twenty":-7.040424,"median":-3.119834,"eighty":-1.974757,"marketCap":297158752},{"date":"2024-04-05","current":-10.36014,"twenty":-7.360002,"median":-3.130675,"eighty":-1.976701,"marketCap":416726253},{"date":"2024-04-12","current":-10.195038,"twenty":-7.620244,"median":-3.158068,"eighty":-1.976701,"marketCap":410085198},{"date":"2024-04-19","current":-7.883612,"twenty":-7.753182,"median":-3.174244,"eighty":-1.980321,"marketCap":317110416},{"date":"2024-04-26","current":-7.658097,"twenty":-7.782413,"median":-3.207973,"eighty":-1.985815,"marketCap":308039288},{"date":"2024-05-03","current":-8.86508,"twenty":-8.098174,"median":-3.224596,"eighty":-1.994569,"marketCap":356588959},{"date":"2024-05-10","current":-8.532119,"twenty":-8.215806,"median":-3.247573,"eighty":-1.999036,"marketCap":343195946},{"date":"2024-05-17","current":-9.212104,"twenty":-8.290722,"median":-3.273439,"eighty":-1.999036,"marketCap":311387542},{"date":"2024-05-24","current":-8.072973,"twenty":-8.40706,"median":-3.295036,"eighty":-1.999036,"marketCap":272882630},{"date":"2024-05-31","current":-8.32061,"twenty":-8.347627,"median":-3.327178,"eighty":-2.004071,"marketCap":281253263},{"date":"2024-06-07","current":-7.329773,"twenty":-8.32061,"median":-3.344736,"eighty":-2.015005,"marketCap":247760983},{"date":"2024-06-14","current":-6.636416,"twenty":-8.310705,"median":-3.372634,"eighty":-2.020335,"marketCap":224324133},{"date":"2024-06-21","current":-6.586891,"twenty":-8.271083,"median":-3.404609,"eighty":-2.021372,"marketCap":222650073},{"date":"2024-06-28","current":-6.537365,"twenty":-8.258961,"median":-3.428089,"eighty":-2.021372,"marketCap":220976012},{"date":"2024-07-05","current":-6.339263,"twenty":-8.236933,"median":-3.45157,"eighty":-2.02236,"marketCap":214279769},{"date":"2024-07-12","current":-7.230722,"twenty":-8.217076,"median":-3.467223,"eighty":-2.027558,"marketCap":244412862},{"date":"2024-07-15","current":-7.626926,"twenty":-8.212596,"median":-3.467223,"eighty":-2.028803,"marketCap":257805347},{"date":"2024-08-02","current":-7.03262,"twenty":-8.208117,"median":-3.469526,"eighty":-2.030049,"marketCap":237716619},{"date":"2024-08-09","current":-6.48784,"twenty":-8.199158,"median":-3.496628,"eighty":-2.03254,"marketCap":219301951},{"date":"2024-08-16","current":-3.603478,"twenty":-8.183187,"median":-3.518664,"eighty":-2.03534,"marketCap":209257587},{"date":"2024-08-23","current":-3.727517,"twenty":-8.147307,"median":-3.578867,"eighty":-2.037206,"marketCap":216460651},{"date":"2024-08-30","current":-3.756413,"twenty":-8.098174,"median":-3.587229,"eighty":-2.041107,"marketCap":218138641},{"date":"2024-09-06","current":-3.525249,"twenty":-8.0757,"median":-3.585926,"eighty":-2.045465,"marketCap":204714725},{"date":"2024-09-13","current":-3.554144,"twenty":-8.073768,"median":-3.584623,"eighty":-2.052458,"marketCap":206392714},{"date":"2024-09-20","current":-3.640831,"twenty":-8.072973,"median":-3.587229,"eighty":-2.063352,"marketCap":211426683},{"date":"2024-09-27","current":-3.438562,"twenty":-8.056855,"median":-3.58304,"eighty":-2.069888,"marketCap":199680756},{"date":"2024-10-04","current":-3.062921,"twenty":-8.009174,"median":-3.566505,"eighty":-2.072817,"marketCap":177866892},{"date":"2024-10-11","current":-3.120712,"twenty":-7.973918,"median":-3.525249,"eighty":-2.078639,"marketCap":181222871},{"date":"2024-10-18","current":-3.467458,"twenty":-7.964126,"median":-3.525249,"eighty":-2.083821,"marketCap":201358746},{"date":"2024-10-25","current":-3.294085,"twenty":-7.923108,"median":-3.525249,"eighty":-2.092846,"marketCap":191290808},{"date":"2024-10-31","current":-3.236294,"twenty":-7.880129,"median":-3.520334,"eighty":-2.099547,"marketCap":187934829},{"date":"2024-11-08","current":-3.90089,"twenty":-7.849549,"median":-3.506811,"eighty":-2.10178,"marketCap":226528589},{"date":"2024-11-15","current":-1.787552,"twenty":-7.782776,"median":-3.516995,"eighty":-2.099547,"marketCap":229884568},{"date":"2024-11-22","current":-1.98327,"twenty":-7.780925,"median":-3.496353,"eighty":-2.090613,"marketCap":255054411},{"date":"2024-11-29","current":-2.322561,"twenty":-7.776424,"median":-3.479178,"eighty":-2.099547,"marketCap":298688264},{"date":"2024-12-06","current":-1.944166,"twenty":-7.775808,"median":-3.467458,"eighty":-2.088379,"marketCap":250025570},{"date":"2024-12-13","current":-1.813685,"twenty":-7.737687,"median":-3.467223,"eighty":-2.074647,"marketCap":233245330},{"date":"2024-12-20","current":-1.552723,"twenty":-7.737687,"median":-3.45157,"eighty":-2.058994,"marketCap":199684851},{"date":"2024-12-27","current":-1.631012,"twenty":-7.721753,"median":-3.438562,"eighty":-2.037206,"marketCap":209752995},{"date":"2025-01-03","current":-2.087695,"twenty":-7.706399,"median":-3.428089,"eighty":-2.034318,"marketCap":268483833},{"date":"2025-01-10","current":-2.113791,"twenty":-7.689891,"median":-3.409667,"eighty":-2.036184,"marketCap":271839881},{"date":"2025-01-17","current":-1.813685,"twenty":-7.669138,"median":-3.39269,"eighty":-2.023348,"marketCap":233245330},{"date":"2025-01-24","current":-1.970262,"twenty":-7.651863,"median":-3.37308,"eighty":-2.013314,"marketCap":253381617},{"date":"2025-01-31","current":-2.087695,"twenty":-7.626926,"median":-3.351876,"eighty":-1.999036,"marketCap":268483833},{"date":"2025-02-07","current":-2.766196,"twenty":-7.618089,"median":-3.346286,"eighty":-2.001554,"marketCap":355741079},{"date":"2025-02-14","current":-2.961917,"twenty":-7.561435,"median":-3.328012,"eighty":-2.013314,"marketCap":380911438},{"date":"2025-02-21","current":-2.661811,"twenty":-7.476213,"median":-3.326343,"eighty":-2.020076,"marketCap":342316887},{"date":"2025-02-28","current":-2.152935,"twenty":-7.418108,"median":-3.294085,"eighty":-2.021372,"marketCap":276873953},{"date":"2025-03-07","current":-2.048551,"twenty":-7.389055,"median":-3.287209,"eighty":-2.021372,"marketCap":263449761},{"date":"2025-03-14","current":-1.813685,"twenty":-7.340634,"median":-3.272498,"eighty":-1.999036,"marketCap":233245330},{"date":"2025-03-21","current":-1.820069,"twenty":-7.329773,"median":-3.248076,"eighty":-1.987869,"marketCap":271679843},{"date":"2025-03-28","current":-2.085772,"twenty":-7.253476,"median":-3.236294,"eighty":-1.98331,"marketCap":311341134},{"date":"2025-04-04","current":-1.747,"twenty":-7.230722,"median":-3.22767,"eighty":-1.976701,"marketCap":260772988},{"date":"2025-04-11","current":-1.607506,"twenty":-7.117897,"median":-3.220305,"eighty":-1.970262,"marketCap":239950810},{"date":"2025-04-17","current":-1.886495,"twenty":-7.102403,"median":-3.19798,"eighty":-1.965533,"marketCap":281595166},{"date":"2025-04-25","current":-2.032632,"twenty":-7.045802,"median":-3.178503,"eighty":-1.957214,"marketCap":303408876},{"date":"2025-05-02","current":-1.95292,"twenty":-7.007874,"median":-3.172829,"eighty":-1.956644,"marketCap":291510488},{"date":"2025-05-09","current":-1.873886,"twenty":-6.986813,"median":-3.154155,"eighty":-1.954076,"marketCap":279713042},{"date":"2025-05-16","current":-2.185868,"twenty":-6.943474,"median":-3.149608,"eighty":-1.95292,"marketCap":325665898},{"date":"2025-05-23","current":-2.708867,"twenty":-6.893948,"median":-3.130675,"eighty":-1.95292,"marketCap":403585960},{"date":"2025-05-30","current":-3.119623,"twenty":-6.884043,"median":-3.124646,"eighty":-1.95292,"marketCap":464783252},{"date":"2025-06-06","current":-3.34168,"twenty":-6.824612,"median":-3.130675,"eighty":-1.953787,"marketCap":497866882}],"updateTime":1749409434094}}}